Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

    Best Selling Products

    BioNewsCast Press Release Distribution Service

    BioNewsCast Press Release Distribution Service

     

    Vaccine Technology 2009 Conference

    Vaccine Technology 2009 Conference

     

    Veterinary Diagnostics Markets

    Veterinary Diagnostics Markets

     

    Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

    Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

     

    Royalty Financing Agreements in Pharma, Biotech and Diagnostics

    Royalty Financing Agreements in Pharma, Biotech and Diagnostics

     

    New Products

    Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment

    Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment

     

    Bioinformatics Market Potential

    Bioinformatics Market Potential

     

    Biotechnology in the European Union; Trends, Investing & Country Profiles

    Biotechnology in the European Union; Trends, Investing & Country Profiles

     

    China Pharmaceutical Industry: Analysis and Market Trends

    China Pharmaceutical Industry: Analysis and Market Trends

     

    European Generic Drug Market Potential

    European Generic Drug Market Potential

     

    Global Biotechnology Markets Trends

    Global Biotechnology Markets Trends

     

    Strategic Alliances in World Pharma and Biotech Markets

    Strategic Alliances in World Pharma and Biotech Markets

     

    Understanding China's Chemical Industry

    Understanding China's Chemical Industry

     

    Understanding Genomics and Global Health Impacts

    Understanding Genomics and Global Health Impacts

     

    Understanding Pharmacogenomics

    Understanding Pharmacogenomics

     

    BioPortfolio | Biotechnology Information Institute |  Biopharmaceutical Expression Systems and Genetic Engineering Technologies

    Biopharmaceutical Expression Systems and Genetic Engineering Technologies

    Biopharmaceutical Expression Systems and Genetic Engineering Technologies


    New expression systems and recent improvements available for current systems have the potential to revolutionize the biopharmaceutical industry!Lower costs and efficiencies of newer expression systems are driving these changes.

    This book provides you with the information you need to make the shift to increased productivity. As reflected by currently marketed products, since the advent of genetic engineering in the 1970s, there has been little basic change in the technologies used for commercial-scale manufacture of biopharmaceutical products.

    Nearly all current products are manufactured using much the same old, familiar technologies – primarily using Esherichia coli (E. coli bacterium), Chinese hamster ovary (CHO) cells and the yeast Saccharomyces cerevisiae (S. cerevisiae) as hosts – technologies invented in the 1970s and commercialized in the 1980s.

    By Ronald A. Rader

    Published by the BioPlan Associates, Inc.

    November 2008

    This book provides you with the information you need to make the shift to increased productivity. As reflected by currently marketed products, since the advent of genetic engineering in the 1970s, there has been little basic change in the technologies used for commercial-scale manufacture of biopharmaceutical products.

    Nearly all current products are manufactured using much the same old, familiar technologies – primarily using Esherichia coli (E. coli bacterium), Chinese hamster ovary (CHO) cells and the yeast Saccharomyces cerevisiae (S. cerevisiae) as hosts – technologies invented in the 1970s and commercialized in the 1980s.
    Table of Contents
    Price: $645.00 / €431.12


    BioPortfolio uses RBS Worldpay Secure Server for credit card transactions